Text Size

Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Vestre VikenHF Kongsberg Sykehus.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Vestre VikenHF Kongsberg Sykehus
ClinicalTrials.gov Identifier:
NCT01283087
First received: January 21, 2011
Last updated: May 26, 2011
Last verified: January 2011
History of Changes
  Purpose

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.


Condition
Transient Neurological Symptoms

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Spinal Anesthesia Using Lidocaine and Sufentanil and TNS (=Transient Neurological Symptoms)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Vestre VikenHF Kongsberg Sykehus:

Estimated Enrollment: 200
Study Start Date: January 2011
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients who are submitted for surgery at a local hospital and where spinal anesthesia is indicated.

Criteria

Inclusion Criteria:

  • adults over the age of eighteen years

Exclusion Criteria:

  • patient refuse spinal anesthesia
  • spinal anesthesia is contraindicated
  • pregnancy
  • patient is incapable of giving consent
  • diabetes
  • neurological disorders
  • chronic pain
  • chronic use of analgesics
  • spinal anesthesia within five days before the actual surgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01283087

Contacts
Contact: Britt-Marie Berling, MD, PhD +4732116000 britt-marie.berling@vestreviken.no

Locations
Norway
Vestre Viken HF Ringerike Sykehus Recruiting
Hønefoss, Norway, NO-3510
Contact: Britt-Marie Berling, MD, PhD     +4732116000     britt-marie.berling@vestreviken.no    
Principal Investigator: Britt-Marie Berling, MD, PhD            
Ringerike Sykehus Recruiting
Hønefoss, Norway, No 3501
Contact: Britt-Marie Berling, MD, PhD     +4732116000     britt-marie.berling@vestreviken.no    
Sponsors and Collaborators
Vestre VikenHF Kongsberg Sykehus
Investigators
Study Chair: halfdan Aas, MD, PhD Vestre Viken HF
Study Chair: halfdan Aas, MD, PhD VestreViken HF
  More Information

No publications provided

Responsible Party: Halfdan Aas, Vestre Viken HF
ClinicalTrials.gov Identifier: NCT01283087     History of Changes
Other Study ID Numbers: 400229
Study First Received: January 21, 2011
Last Updated: May 26, 2011
Health Authority: Norway: Directorate of Health

Keywords provided by Vestre VikenHF Kongsberg Sykehus:
TNS
Spinal anesthesia
Lidocaine

Additional relevant MeSH terms:
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Anesthetics
Lidocaine
Sufentanil
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
 Anesthetics, Local
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Cardiovascular Agents
Analgesics, Opioid
Analgesics
Adjuvants, Anesthesia
Narcotics
Anesthetics, Intravenous
Anesthetics, General

ClinicalTrials.gov processed this record on May 23, 2013